Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'cytosine arabinoside' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 993 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Howell, SB
      Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoam (TM) technology

      CANCER JOURNAL
    2. Uyl-de Groot, CA; Hartog, JGD; Huijgens, PC; Willemze, R; Van Ineveld, BM
      Costs of diagnosis, treatment, and follow up of patients with acute myeloid leukemia in the Netherlands

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    3. Gaubert, G; Gosselin, G; Eriksson, S; Vita, A; Maury, G
      Unnatural enantiomers of 5-azacytidine analogues: Syntheses and enzymatic properties

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    4. Burnett, AK
      Treatment of acute myeloid leukaemia in younger patients

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    5. Sievers, EL
      Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse

      EXPERT OPINION ON BIOLOGICAL THERAPY
    6. Houze, P; Deschamps, F; Dombret, H; Bousquet, B; Gourmel, B
      Micellar electrokinetic capillary chromatography quantification of cytosine arabinoside and its metabolite, uracil arabinoside, in human serum

      JOURNAL OF CHROMATOGRAPHY B
    7. Jelic, S; Babovic, N; Stamatovic, L; Kreacic, M; Matkovic, S; Popov, I
      Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center study

      MEDICAL ONCOLOGY
    8. Levy, RM; Major, E; Ali, MJ; Cohen, B; Groothius, D
      Convection-enhanced intraparenchymal delivery (CEID) of cytosine arabinoside (AraC) for the treatment of HIV-related progressive multifocal leukoencephalopathy (PML)

      JOURNAL OF NEUROVIROLOGY
    9. Bross, PF; Beitz, J; Chen, G; Chen, XH; Duffy, E; Kieffer, L; Roy, S; Sridhara, R; Rahman, A; Williams, G; Pazdur, R
      Approval summary: Gemtuzumab ozogamicin in relapsed acute myeloid leukemia

      CLINICAL CANCER RESEARCH
    10. Taub, JW
      Relationship of chromosome 21 and acute leukemia in children with Down syndrome

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    11. Segarra-Newnham, M; Vodolo, KM
      Use of cidofovir in progressive multifocal leukoencephalopathy

      ANNALS OF PHARMACOTHERAPY
    12. Lindauer, M; Fischer, T
      Interferon-alpha combined with cytarabine in chronic myelogenous leukemia - Clinical benefits

      LEUKEMIA & LYMPHOMA
    13. Vidarsson, B; Abonour, R; Williams, EC; Woodson, RD; Turman, NJ; Kim, K; Mosher, DF; Wiersma, SR; Longo, WL
      Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia

      LEUKEMIA & LYMPHOMA
    14. Preisler, HD; Venugopal, P; Gregory, SA; Adler, S; Gezer, S; Hsu, WT; Manson, S; Larson, A; Jajeh, A; Slvinick, D; Galvez, A
      High remission rate in acute myeloblastic leukemia with only two days of chemotherapy

      LEUKEMIA & LYMPHOMA
    15. Beck, JR; Guilhot, J; Giles, FJ; Aoki, N; Wirt, DP; Guilhot, F
      Cytarabine added to interferon improves the cost-effectiveness of initial therapy for patients with early chronic phase chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    16. Carella, AM; Cascavilla, N; Greco, MM; Melillo, L; Sajeva, MR; Ladogana, S; D'Arena, G; Perla, G; Carotenuto, M
      Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (FLAG regimen): A single center study

      LEUKEMIA & LYMPHOMA
    17. Clavio, M; Gatto, S; Beltrami, G; Cerri, R; Carrara, P; Pierri, I; Canepa, L; Miglino, M; Balleari, E; Masoudi, B; Damasio, E; Ghio, R; Sessarego, M; Gobbi, M
      First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia

      LEUKEMIA & LYMPHOMA
    18. Bohgaki, T; Notoya, A; Kondo, M; Mukai, M; Kohno, M
      Leukemia cutis in an elderly patient treated with low dose cytosine arabinoside and etoposide

      LEUKEMIA & LYMPHOMA
    19. Pinto, A; Zagonel, V; Ferrara, F
      Acute myeloid leukemia in the elderly: biology and therapeutic strategies

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    20. Kerr, JZ; Berg, S; Blaney, SM
      Intrathecal chemotherapy

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    21. Du, LT; Smolewski, P; Bedner, E; Traganos, F; Darzynkiewicz, Z
      Selective protection of mitogenically stimulated human lymphocytes but notleukemic cells from cytosine arabinoside-induced apoptosis by LY294002, a phosphoinositol-3 kinase inhibitor

      INTERNATIONAL JOURNAL OF ONCOLOGY
    22. Hernandez-Boluda, JC; Cervantes, F; Alvarez, A; Costa, D; Montserrat, E
      Single-agent therapy with oral mercaptopurine for nonlymphoid blast crisisof chronic myeloid leukemia

      ANNALS OF HEMATOLOGY
    23. Kern, W; Schleyer, E; Braess, J; Wittmer, E; Ohnesorge, J; Unterhalt, M; Wormann, B; Buchner, T; Hiddemann, W
      Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone [FIS-HAM] salvage therapy in highly resistant acuteleukemias

      ANNALS OF HEMATOLOGY
    24. Beausejour, CM; Eliopoulos, N; Momparler, L; Le, NLO; Momparler, RL
      Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene

      CANCER GENE THERAPY
    25. Cha, KE; Yoon, SY; Lee, KN
      Effect of granulocyte colony-stimulating factor on chemotherapeutic activity of cytosine arabinoside in acute leukemic cell lines

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    26. Morikawa, N; Mori, T; Kawashima, H; Takeyama, M; Abe, T; Kobayashi, H
      Pharmacokinetics of nimustine, cytosine arabinoside, and methotrexate in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    27. Yamauchi, T; Kawai, Y; Goto, N; Kishi, S; Imamura, S; Yoshida, A; Urasaki, Y; Fukushima, T; Iwasaki, H; Tsutani, H; Masada, M; Ueda, T
      Close correlation of 1-beta-D-arabinofuranosylcytosine 5 '-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N-4-behenoyl-1-beta-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia

      JAPANESE JOURNAL OF CANCER RESEARCH
    28. Yamauchi, T; Kawai, Y; Kishi, S; Goto, N; Urasaki, Y; Imamura, S; Fukushima, T; Yoshida, A; Iwasaki, H; Tsutani, H; Masada, M; Ueda, T
      Monitoring of intracellular 1-beta-D-arabinofuranosylcytosine 5 '-triphosphate in 1-beta-D-arabinofuranosylcytosine therapy at low and conventional doses

      JAPANESE JOURNAL OF CANCER RESEARCH
    29. Ben-Ishay, Z; Barak, V
      Bone marrow stromal dysfunction in mice administered cytosine arabinoside

      EUROPEAN JOURNAL OF HAEMATOLOGY
    30. Norgaard, JM; Langkjer, ST; Palshof, T; Pedersen, B; Hokland, P
      Pretreatment leukaemia cell drug resistance is correlated to clinical outcome in acute myeloid leukaemia

      EUROPEAN JOURNAL OF HAEMATOLOGY
    31. Garcia-Manero, G; Thomas, DA
      Salvage therapy for refractory or relapsed acute lymphocytic leukemia

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    32. Visani, G; Milligan, D; Leoni, F; Chang, J; Kelsey, S; Marcus, R; Powles, R; Schey, S; Covelli, A; Isidori, A; Litchman, M; Piccaluga, PP; Mayer, H; Malagola, M; Pfister, C
      Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia

      LEUKEMIA
    33. Radosevic, N; Delmer, A; Tang, R; Marie, JP; Ajchenbaum-Cymbalista, F
      Cell cycle regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure

      LEUKEMIA
    34. Rowe, JM
      Uncertainties in the standard care of acute myelogenous leukemia

      LEUKEMIA
    35. van den Berg, H; van der Flier, M; van de Wetering, MD
      Cytarabine-induced aseptic meningitis

      LEUKEMIA
    36. Jahns-Streubel, G; Braess, J; Schoch, C; Fonatsch, C; Haase, D; Binder, C; Wormann, B; Buchner, T; Hiddemann, W
      Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF

      LEUKEMIA
    37. Ahlmann, M; Lanvers, C; Lumkemann, K; Rossig, C; Freund, A; Baumann, M; Boos, J
      Modulation of ara-CTP levels by fludarabine and hydroxyurea in leukemic cells

      LEUKEMIA
    38. Shanholtz, C
      Acute life-threatening toxicity of cancer treatment

      CRITICAL CARE CLINICS
    39. Sievers, EL; Larson, RA; Stadtmauer, EA; Estey, E; Lowenberg, B; Dombret, H; Karanes, C; Theobald, M; Bennett, JM; Sherman, ML; Berger, MS; Eten, CB; Loken, MR; van Dongen, JJM; Bernstein, ID; Appelbaum, FR
      Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

      JOURNAL OF CLINICAL ONCOLOGY
    40. Creutzig, U; Ritter, J; Zimmermann, M; Reinhardt, D; Hermann, J; Berthold, F; Henze, G; Jurgens, H; Kabisch, H; Havers, W; Reiter, A; Kluba, U; Niggli, F; Gadner, H
      Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: Results of study Acute Myeloid Leukemia - Berlin-Frankfurt-Munster 93

      JOURNAL OF CLINICAL ONCOLOGY
    41. Clavio, M; Quintino, S; Masoudi, B; Carrara, S; Cerri, R; Pierri, I; Canepa, L; Miglino, M; Muner, P; Damasio, E; Gobbi, M
      Cost of de novo acute myeloid leukemia induction therapy in adults: Analysis of EORTC-GIMEMA AML10 and FLANG regimens

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    42. Kanda, Y; Matsumura, T; Maki, K; Matsuyama, T; Chiba, S; Hirai, H
      Fatal cardiac toxicity in two patients receiving same-day administration of cyclophosphamide and cytarabine as conditioning for hematopoietic stem cell transplantation

      HAEMATOLOGICA
    43. Cervantes, F; Sureda, A; Hernandez-Boluda, JC; Martino, R; Brunet, S; Borrego, D; Antich, JL; Montserrat, E
      Interferon alpha plus intermittent oral Ara-C ocfosfate (YNK-01) in chronic myeloid leukemia primarily resistant or with minimal cytogenetic responseto interferon

      HAEMATOLOGICA
    44. Uderzo, C; Conter, V; Dini, G; Locatelli, F; Miniero, R; Tamaro, P
      Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies

      HAEMATOLOGICA
    45. Hanel, M; Friedrichsen, K; Hanel, A; Herbst, R; Morgner, A; Neser, S; Nicklisch, M; Teich, M; Ehninger, G; Fiedler, F
      Mito-FLAG as salvage therapy for relapsed and refractory acute myeloid leukemia

      ONKOLOGIE
    46. Lee, ST; Jang, JH; Suh, HC; Hahn, JS; Ko, YW; Min, YH
      Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome

      AMERICAN JOURNAL OF HEMATOLOGY
    47. Barone, S; Baer, MR; Sait, SNJ; Lawrence, D; Block, AW; Wetzler, M
      High-dose cytosine arabinoside and idarubicin treatment of chronic myeloidleukemia in myeloid blast crisis

      AMERICAN JOURNAL OF HEMATOLOGY
    48. Lennard, L
      Therapeutic drug monitoring of cytotoxic drugs

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    49. Rideout, HJ; Zang, E; Yeasmin, M; Gordon, R; Jabado, O; Park, DS; Stefanis, L
      Inhibitors of trypsin-like serine proteases prevent DNA damage-induced neuronal death by acting upstream of the mitochondrial checkpoint and of p53 induction

      NEUROSCIENCE
    50. Creutzig, U; Berthold, F; Boos, J; Fleischhack, G; Gadner, H; Gnekow, A; Graubner, U; Henze, G; Hermann, J; Imbach, P; Jurgens, H; Kabisch, H; Korholz, D; Niemeyer, CM; Reinhardt, D; Reiter, A; Ritter, J; Spaar, HJ; Zimmermann, M
      Improved treatment results in children with AML: Results of study AML-BFM 93

      KLINISCHE PADIATRIE
    51. Kimby, E; Nygren, P; Glimelius, B
      A systematic overview of chemotherapy effects in acute myeloid leukaemia

      ACTA ONCOLOGICA
    52. Kalaycio, M; Pohlman, B; Elson, P; Lichtin, A; Hussein, M; Tripp, B; Andresen, S
      Chemotherapy for acute myelogenous leukemia in the elderly with cytarabine, mitoxantrone, and granulocyte-macrophage colony-stimulating factor

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    53. Levkovitz, Y; Baraban, JM
      A dominant negative inhibitor of the Egr family of transcription regulatory factors suppresses cerebellar granule cell apoptosis by blocking c-Jun activation

      JOURNAL OF NEUROSCIENCE
    54. Morris, EJ; Keramaris, E; Rideout, HJ; Slack, RS; Dyson, NJ; Stefanis, L; Park, DS
      Cyclin-dependent kinases and P53 pathways are activated independently and mediate bax activation in neurons after DNA damage

      JOURNAL OF NEUROSCIENCE
    55. Ge, YB; Konrad, MA; Matherly, LH; Taub, JW
      Transcriptional regulation of the human cystathionine beta-synthase-1b basal promoter: synergistic transactivation by transcription factors NF-Y and Sp1/Sp3

      BIOCHEMICAL JOURNAL
    56. Arboscello, E; Botta, M; Romero, D; Schenone, E; Mencoboni, M; Bogliolo, G; Pannacciulli, I
      Effects of retinoic acid and amifostine on in vitro growth of normal hemopoietic progenitor cells

      ANTICANCER RESEARCH
    57. Seil, FJ
      Interactions between cerebellar Purkinje cells and their associated astrocytes

      HISTOLOGY AND HISTOPATHOLOGY
    58. Holstein, SA; Hohl, RJ
      Interaction of cytosine arabinoside and lovastatin in human leukemia cells

      LEUKEMIA RESEARCH
    59. Bahng, H; Lee, JH; Ahn, JH; Lee, JH; Lee, JS; Kim, SH; Kim, WK; Lee, KH
      Combination chemotherapy utilizing continuous infusion of intermediate-dose cytarabine for refractory or recurrent acute myeloid leukemia

      LEUKEMIA RESEARCH
    60. Feldman, EJ
      Commentary: dose intensive chemotherapy in acute myeloid leukemia

      LEUKEMIA RESEARCH
    61. Ek, T; Jarfelt, M; Mellander, L; Abrahamsson, J
      Proinflammatory cytokines mediate the systemic inflammatory response associated with high-dose cytarabine treatment in children

      MEDICAL AND PEDIATRIC ONCOLOGY
    62. Loeb, DM; Bowers, DC; Civin, CI; Friedman, AD
      Intensive timed sequential remission induction chemotherapy with high-dosecytarabine for childhood acute myeloid leukemia

      MEDICAL AND PEDIATRIC ONCOLOGY
    63. Harila-Saari, AH; Huuskonen, UEJ; Tolonen, U; Vainionpaa, LK; Lanning, BM
      Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: A study with motor evoked potentials

      MEDICAL AND PEDIATRIC ONCOLOGY
    64. Lowenberg, B
      Managing therapy in older adult patients with acute myeloid leukemia

      SEMINARS IN HEMATOLOGY
    65. Stone, RM
      Postremission therapy in adults with acute myeloid leukemia

      SEMINARS IN HEMATOLOGY
    66. Robak, T; Gora-Tybor, J
      Cladribine combined with mitoxantrone in the treatment of blastic phase ofchronic myeloid leukemia

      NEOPLASMA
    67. Afenya, EK
      Recovery of normal hemopoiesis in disseminated cancer therapy - a model

      MATHEMATICAL BIOSCIENCES
    68. Maruyama, W; Akao, Y; Youdim, MBH; Davis, BA; Naoi, M
      Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol

      JOURNAL OF NEUROCHEMISTRY
    69. Ge, YB; Matherly, LH; Taub, JW
      Transcriptional regulation of cell-specific expression of the human cystathionine beta-synthase gene by differential binding of Sp1/Sp3 to the-1b promoter

      JOURNAL OF BIOLOGICAL CHEMISTRY
    70. Mazur, DJ; Perrino, FW
      Excision of 3 ' termini by the Trex1 and TREX2 3 '-> 5 ' exonucleases - Characterization of the recombinant proteins

      JOURNAL OF BIOLOGICAL CHEMISTRY
    71. Pham, NA; Hedley, DW
      Respiratory chain-generated oxidative stress following treatment of leukemic blasts with DNA-damaging agents

      EXPERIMENTAL CELL RESEARCH
    72. Shi, Z; Azuma, A; Sampath, D; Li, YX; Huang, P; Plunkett, W
      S-phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine

      CANCER RESEARCH
    73. Takemura, H; Urasaki, Y; Yoshida, A; Fukushima, T; Ueda, T
      Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells

      CANCER RESEARCH
    74. Beran, M; Shen, Y; Kantarjian, H; O'Brien, S; Koller, CA; Giles, FJ; Cortes, J; Thomas, DA; Faderl, S; Despa, S; Estey, EH
      High-dose chemotherapy in high-risk myelodysplastic syndrome - Covariate-adjusted comparison of five regimens

      CANCER
    75. Kantarjian, HM; Shan, JQ; Smith, T; Talpaz, M; Kozuch, P; Rios, MB; Cortes, J; Giles, FJ; O'Brien, S
      Response to therapy is independently associated with survival prolongationin chronic myelogenous leukemia in the blastic phase

      CANCER
    76. Cortes, J; Estey, E; O'Brien, S; Giles, F; Shen, Y; Koller, C; Beran, M; Thomas, D; Keating, M; Kantarjian, H
      High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia

      CANCER
    77. Thomas, X; Berhabri, A
      Acute myeloid leukemia in the elderly: a review

      BULLETIN DU CANCER
    78. Mansson, E; Paul, A; Lofgren, C; Ullberg, K; Paul, C; Eriksson, S; Albertioni, F
      Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy

      BRITISH JOURNAL OF HAEMATOLOGY
    79. Camba, L; Aldrighetti, L; Ciceri, F; Bernardi, M; Marktel, S; Angeli, E; Giacomelli, M
      Locoregional intrasplenic chemotherapy for hypersplenism in myelofibrosis

      BRITISH JOURNAL OF HAEMATOLOGY
    80. Braess, J; Jahns-Streubel, G; Schoch, C; Haase, D; Haferlach, T; Fiegl, M; Voss, S; Kern, W; Schleyer, E; Hiddemann, W
      Proliferative activity of leukaemic blasts and cytosine arabinoside pharmacodynamics are associated with cytogenetically defined prognostic subgroupsin acute myeloid leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    81. Yin, JAL; Wheatley, K; Rees, JKH; Burnett, AK
      Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial

      BRITISH JOURNAL OF HAEMATOLOGY
    82. Matthews, JP; Bishop, JF; Young, GAR; Juneja, SK; Lowenthal, RM; Garson, OM; Cobcroft, RG; Dodds, AJ; Enno, A; Gillett, EA; Hermann, RP; Joshua, DE; Ma, DD; Szer, J; Taylor, KM; Wolf, M; Bradstock, KF
      Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    83. Jackson, G; Taylor, P; Smith, GM; Marcus, R; Smith, A; Chu, P; Littlewood, TJ; Duncombe, A; Hutchinson, M; Mehta, AB; Johnson, SA; Carey, P; Mackie, MJ; Ganly, PS; Turner, GE; Deane, M; Schey, S; Brookes, J; Tollerfield, SM; Wilson, MP
      A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation

      BRITISH JOURNAL OF HAEMATOLOGY
    84. Sargent, JM; Elgie, AW; Williamson, CJ; Lewandowicz, GM; Taylor, CG
      Circumvention of ara-C resistance by aphidicolin in blast cells from patients with AML

      BRITISH JOURNAL OF CANCER
    85. Galmarini, CM; Graham, K; Thomas, X; Calvo, F; Rousselot, P; El Jafaari, A; Cros, E; Mackey, JR; Dumontet, C
      Expression of high Km 5 '-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia

      BLOOD
    86. Carbone, GMR; Catapano, CV; Fernandes, DJ
      Imbalanced DNA synthesis induced by cytosine arabinoside and fludarabine in human leukemia cells

      BIOCHEMICAL PHARMACOLOGY
    87. Csapo, Z; Sasvari-Szekely, M; Spasokoukotskaja, T; Talianidis, I; Eriksson, S; Staub, M
      Activation of deoxycytidine kinase by inhibition of DNA synthesis in humanlymphocytes

      BIOCHEMICAL PHARMACOLOGY
    88. Bergman, AM; Munch-Petersen, B; Jensen, PB; Sehested, M; Veerman, G; Voorn, DA; Smid, K; Pinedo, HM; Peters, GJ
      Collateral sensitivity to gemcitabine (2 ',2 ' -difluorodeoxycytidine) andcytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines

      BIOCHEMICAL PHARMACOLOGY
    89. Allio, T; Donner, EM; Preston, RJ
      A comparison of the roles of p53 mutation and AraC inhibition in the enhancement of bleomycin-induced chromatid aberrations in mouse and human cells

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    90. Miller, FD; Pozniak, CD; Walsh, GS
      Neuronal life and death: an essential role for the p53 family

      CELL DEATH AND DIFFERENTIATION
    91. Chamberlain, MC
      Neoplastic meningitis: a guide to diagnosis and treatment

      CURRENT OPINION IN NEUROLOGY
    92. Williams, JP; Handler, HL
      Antibody-targeted chemotherapy for the treatment of relapsed acute myeloidleukemia

      AMERICAN JOURNAL OF MANAGED CARE
    93. Berman, E
      Recent advances in the treatment of acute leukemia: 1999

      CURRENT OPINION IN HEMATOLOGY
    94. Rowe, JM
      Concurrent use of growth factors and chemotherapy in acute leukemia

      CURRENT OPINION IN HEMATOLOGY
    95. Treish, IM
      Targeting leukemia cells with gemtuzumab ozogamicin

      CANCER PRACTICE
    96. Keramaris, E; Stefanis, L; MacLaurin, J; Harada, N; Takaku, K; Ishikawa, T; Taketo, MM; Robertson, GS; Nicholson, DW; Slack, RS; Park, DS
      Involvement of caspase 3 in apoptotic death of cortical neurons evoked by DNA damage

      MOLECULAR AND CELLULAR NEUROSCIENCE
    97. Ferra, C; Berlanga, JJ; Gallardo, D; Ancin, I; Marin, D; Gonzalez, JR; Peris, J; Munoz, J; Sarra, J; Granena, A
      Mitoxantrone, etoposide, carboplatinum and ara-C combination therapy (Meca) in refractory and relapsed acute leukemia

      LEUKEMIA & LYMPHOMA
    98. Robak, T; Wrzesien-Kus, A; Lech-Maranda, E; Kowal, M; Dmoszynska, A
      Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine andG-CSF (CLAG) as induction therapy for patients with relapsed or refractoryacute myeloid leukemia

      LEUKEMIA & LYMPHOMA
    99. Katagiri, T; Miyazawa, K; Nishimaki, J; Yaguchi, M; Kawanishi, Y; Ohyashiki, K
      Combination of granulocyte colony-stimulating factor and low-dose cytosinearabinoside further enhances myeloid differentiation in leukemia cells in vitro

      LEUKEMIA & LYMPHOMA
    100. Feldman, EJ; Seiter, K; Traganos, F; Darzynkiewicz, Z; Goff, H; Pozzuoli, M; Baskind, P; Santos, S; Ahmed, T
      Phase II evaluation of a high-dose mitoxantrone based induction regimen inuntreated adults with acute myeloid leukemia

      LEUKEMIA & LYMPHOMA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 08:54:50